AMR three-lens brief
Evidence-based stock research on AMR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.06% yesterday. · P/E of 75 — priced for high growth; little margin of safety.
- Moved -4.06% yesterday.
- Outperforming SPY by 52.6pp over 30 days.
- P/E of 75 — priced for high growth; little margin of safety.
- Analyst mean target $180.00 — 17% below current (3 analysts).
AMR closed at $217.73 (-4.06%) as of 2026-09-11. Market cap: $2.76B. P/E (trailing) 75.5. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 52.6pp over 30 days.. Concerns: moved -4.06% yesterday.; p/E of 75 — priced for high growth; little margin of safety.. Last quarter: Revenue $492.86M, net income -$12.25M, free cash flow $52.46M.
Why three lenses on AMR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMR brief"></iframe>